Elekta adds Implant's brachytherapy TPS (treatment planning system) to prostrate cancer solutions:
This article was originally published in Clinica
Executive Summary
Swedish group Elekta has rolled out the worldwide distribution of Implant Sciences' I-Plant brachytherapy treatment planning system (TPS) for prostate cancer, following an exclusive supply and distribution agreement between the two companies. Wakefield, Massachusetts-based Implant's current version of I-Plant TPS incorporates the treatment planning technology acquired from Rosses Medical Systems in fiscal 2005 and contains a new module that allows doctors to make two- and three-dimensional maps of stage, grade and location of cancer within the prostate gland.